Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ING2 | Q9H160 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.53 |
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | CA12 | O43570 | 3/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.42 |
| ▸ | DRD1 | P21728 | 2/20 | 0.42 |
| ▸ | DRD5 | P21918 | 2/20 | 0.42 |
| ▸ | DRD3 | P35462 | 2/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29642689 | 1.00 | ING2 (0.53) | ING2CA1CA2CA12CA7 | |
| SCHEMBL11589913 | 0.94 | ING2 (0.59) | ING2CA1CA2CA12CA7 | |
| SCHEMBL28620166 | 0.94 | ING2 (0.59) | ING2CA1CA2CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL27289512 | 0.92 | ING2 (0.57) | ING2CA1CA2CA12CA7 | |
| SCHEMBL15851432 | 0.87 | KDM4E (0.57) | ING2CA1CA2CA12CA7 | |
| Potassium SCHEMBL10575068 | 0.85 | KDM4E (0.56) | ING2CA1CA2CA12CA7 | |
| SCHEMBL9786190 | 0.83 | KMT2A (0.58) | ING2CA1CA2CA12CA7 | |
| SCHEMBL2951392 | 0.83 | KMT2A (0.58) | ING2CA1CA2CA12CA7 | |
| Potassium SCHEMBL2956797 | 0.82 | KMT2A (0.56) | ING2CA1CA2CA12CA7 | |
| SCHEMBL9786185 | 0.82 | KMT2A (0.56) | ING2CA1CA2CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616449-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | Dundalk Institute of Technology (IE) | 2013-07-24 | — | — | EP | claimed |
| WO-2012035122-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2012-03-22 | — | — | WO | claimed |
| WO-2021022258-A1 | TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF HEMATOLOGICAL CANCERS | TETRAPHASE PHARMACEUTICALS, INC. (US) | 2021-02-04 | — | — | WO | disclosed |
| US-20150119356-A1 | Ophthalmic Viscoelastic Device | CARL ZEISS MEDITEC AG (DE) | 2015-04-30 | — | — | US | disclosed |
| EP-2846848-A1 | OPHTHALMIC VISCOELASTIC DEVICE | Carl Zeiss Meditec AG (DE) | 2015-03-18 | — | — | EP | disclosed |
| WO-2013167632-A1 | OPHTHALMIC VISCOELASTIC DEVICE | CARL ZEISS MEDITEC AG (DE) | 2013-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119356-A1 | Ophthalmic Viscoelastic Device | UACA, ICAM1, VIM | ING2 737/4885CA1 4767/4885CA2 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.